Related Experiment Video
Updated: May 2, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
[Antitachycardia pacing for atrial tachyarrhythmias]
1Herzzentrum, Zentralklinik Bad Berka Robert Koch Allee 9 99437 Bad Berka, Germany Tel.: 036458/50 E-Mail: BVEHuegl@aol.com, DE.
Abstract:
Overdrive pacing therapies are well established to treat patients with ventricular tachycardia. The main advantage is the quick and painless success with a high efficacy. Newer observations show that atrial arrhythmias with short cycle lengths (<200ms) can be terminated by painless overdrive pacing therapies as well. In the AT500 verification study and in the Jewel AF-trial, 30-60% of all treated atrial arrhythmias could be terminated by overdrive pacing. Nevertheless, these encouraging results need to be confirmed by additional randomized clinical trials. Especially the "hybrid" therapy (overdrive pacing in combination with an antiarrhythmic drug therapy) looks promising.
Related Concept Videos
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias

